RESEARCH ALK+ UK
To protect and promote the health of the public through supporting research into the nature, causes, diagnosis, prevention, treatment and cure of anaplastic lymphoma kinase positive (or ALK positive, non-small cell lung cancer).
Objects
TO PROTECT AND PROMOTE THE HEALTH OF THE PUBLIC THROUGH SUPPORTING RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF ANAPLASTIC LYMPHOMA KINASE POSITIVE (OR ALK+, NON-SMALL CELL LUNG CANCER
Financial health, per its FY2025 accounts
The accounts state that the charity incurred a net expenditure of £89,621 in the year ended 31 March 2025, significantly reducing its unrestricted funds from £110,192 to £20,571. The trustees report that there are no material uncertainties regarding the charity's ability to continue as a going concern. The charity's objective is to fund research, evidenced by a £120,910 donation made to lung cancer research in the USA.
What the accounts disclose
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints policy and procedures
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Volunteers: 20
Self-declared on the annual return for the financial year ending 31/03/2024
- Volunteers: 5
Self-declared on the annual return for the financial year ending 31/03/2023
- Volunteers: 5
Annual return filing dates (Charity Commission record)
Of its last 4 annual returns with a recorded received date, 1 was received after the due date: year ending 31/03/2023 (received 07/02/2024, 7 days after the 31/01/2024 due date).
Trustees
- Aileen Murgatroydchair
- Colin Blackaby
- KELVIN FITTON BA FCA
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £34k | £124k |
| 31/03/2024 | £71k | £11k |
| 31/03/2023 | £41k | £0 |
| 31/03/2022 | £18k | £0 |
Common questions
Is RESEARCH ALK+ UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity incurred a net expenditure of £89,621 in the year ended 31 March 2025, significantly reducing its unrestricted funds from £110,192 to £20,571. The trustees report that there are no material uncertainties regarding the charity's ability to continue as a going concern. The charity's objective is to fund research, evidenced by a £120,910 donation made to lung cancer research in the USA. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| PEACOCK CHARITABLE TRUST | 3 | £390k |
| DAVID LISTER CHARITABLE TRUST | 3 | £171k |
| THE GEORGE CADBURY TRUST (GEORGE HENRY T AND LAURENCE J CADBURY SECTIONS) | 3 | £122k |
| MILLS AND REEVE CHARITABLE TRUST | 3 | £10k |
| CHILDREN WITH CANCER UK | 2 | £3.3m |
| THE PENNIES FOUNDATION | 2 | £99k |
| SANDRA CHARITABLE TRUST | 2 | £47k |
| THE CYRIL AND EVE JUMBO CHARITABLE TRUST | 2 | £26k |
Charities like this
- ALK POSITIVE LUNG CANCER (UK)
- CANCER RESEARCH UK
- Asthma and Lung UK
- THE ANTHONY LONG CHARITABLE TRUST
- Blood Cancer UK Research
- YORKSHIRE CANCER RESEARCH
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| RESEARCH ALK+ UK | £34k | — | 0 | unclear | — | no doubt |
| ALK POSITIVE LUNG CANCER (UK) | £274k | — | — | unclear | — | no doubt |
| CANCER RESEARCH UK | £734.8m | — | 380 | above | 22.0% | no doubt |
| Asthma and Lung UK | £16.1m | — | — | unclear | — | no doubt |
| THE ANTHONY LONG CHARITABLE TRUST | £39k | — | 0 | unclear | — | no doubt |
| Blood Cancer UK Research | £21.1m | — | — | unclear | — | no doubt |